Characterizing infection in anti-neutrophil cytoplasmic antibody-associated vasculitis:results from a longitudinal, matched-cohort data linkage study [PDF]
, 2020 Objectives: Infection exerts a major burden in ANCA-associated vasculitis (AAV), however, its precise extent and nature remains unclear. In this national study we aimed to longitudinally quantify, characterize and contextualize infection risk in AAV ...
Amft, Nicole +11 more
core +6 more sources
The now of scientific events in rheumatology
Global Rheumatology, 2020 In 2020, one by one, the scientific events in all areas of knowledge scheduled to take place, on a personal-attendance basis, were gradually cancelled, although most of them were virtually rescheduled, this situation forced a quick adaptation regarding ...
Global Rheumatology by PANLAR
doaj +1 more source
How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs?
Journal of Infection in Developing Countries, 2023 Introduction: We aimed to investigate the effects of the coronavirus disease 2019 (COVID-19) pandemic on the course and treatment of patients with inflammatory rheumatic musculoskeletal disease (iRMD) using biologic or targeted synthetic disease ...
Semih Gulle +9 more
doaj +1 more source
The prevalence of fibromyalgia in the general population : A comparison of the American College of Rheumatology 1990, 2010 and modified 2010 classification criteria [PDF]
, 2014 Copyright © 2014 American College of Rheumatology.
Atzeni, Fabiola +5 more
core +2 more sources
Telerheumatology during the COVID-19 pandemic: Impact on clinical practice, education, and research
Indian Journal of Rheumatology, 2022 Telerheumatology, the use of telemedicine in the provision of rheumatology care, has been on the periphery of rheumatology practice for several years. However, the need for remote rheumatology service has emerged during the COVID-19 pandemic in order to ...
Su Ann Yeoh +1 more
doaj +1 more source
Experience with the use of Rituximab for the treatment of rheumatoid arthritis in a tertiary Hospital in Spain: RITAR study [PDF]
, 2019 There is evidence supporting that there are no relevant clinical differences between dosing rituximab 1000 mg or 2000 mg per cycle in rheumatoid arthritis (RA) patients in clinical trials, and low-dose cycles seem to have a better safety profile ...
Alvaro García, José M. +11 more
core +2 more sources
Global Rheumatology, 2020 Discuss how the clinic responded to the need to evaluate patients in non-presential environments. As well as to identify the main limitations of these strategies and the available success stories.
Global Rheumatology by PANLAR
doaj +1 more source
High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial [PDF]
, 2016 Objectives: To determine whether prolonged intensive disease-modifying antirheumatic drug (DMARD) treatment (PRINT) leads to high remission and low relapse rates in patients with severe rheumatoid arthritis (RA).
Chen, Li-Na +24 more
core +3 more sources
Meeting the challenge for foot health in rheumatic diseases [PDF]
, 2004 Background: National guidelines recommend that patients with rheumatic diseases should have access to podiatry services and evidence is emerging that podiatry interventions are effective in the management of foot problems in this patient group.
Bowden, AP, Williams, AE
core +1 more source
Global Rheumatology, 2020 Since 1996, October 12th is recognized as World Arthritis Day. A global initiative bringing people together to raise awareness of rheumatic and musculoskeletal diseases (RMDs), established by Arthritis and Rheumatism International (ARI) and managed by ...
Global Rheumatology by PANLAR
doaj +1 more source